Epigenetic modulation of antitumor immunity for improved cancer immunotherapy

E Dai, Z Zhu, S Wahed, Z Qu, WJ Storkus, ZS Guo - Molecular cancer, 2021 - Springer
Epigenetic mechanisms play vital roles not only in cancer initiation and progression, but also
in the activation, differentiation and effector function (s) of immune cells. In this review, we …

Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study

YL Wu, ZJ Lin, CC Li, X Lin, SK Shan, B Guo… - … and Targeted Therapy, 2023 - nature.com
Epigenetics regulates gene expression and has been confirmed to play a critical role in a
variety of metabolic diseases, such as diabetes, obesity, non-alcoholic fatty liver disease …

LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond

W Huang, H Li, Q Yu, W Xiao, DO Wang - Journal of Experimental & …, 2022 - Springer
DNA methylation is one of the most important epigenetic mechanisms to regulate gene
expression, which is highly dynamic during development and specifically maintained in …

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

X Xu, Q Peng, X Jiang, S Tan, Y Yang… - … & Molecular Medicine, 2023 - nature.com
Metabolic reprogramming and epigenetic modifications are hallmarks of cancer cells. In
cancer cells, metabolic pathway activity varies during tumorigenesis and cancer …

TET (Ten-eleven translocation) family proteins: Structure, biological functions and applications

X Zhang, Y Zhang, C Wang, X Wang - Signal Transduction and …, 2023 - nature.com
Ten-eleven translocation (TET) family proteins (TETs), specifically, TET1, TET2 and TET3,
can modify DNA by oxidizing 5-methylcytosine (5mC) iteratively to yield 5 …

[HTML][HTML] Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson's disease

Y Açar, D Ağagündüz, P De Cicco… - Biomedicine & …, 2023 - Elsevier
Abstract Parkinson's Disease (PD), a neurodegenerative disorder, is characterized by the
degeneration of progressive dopaminergic (DA) neurons in the substantia nigra region of …

Neuronal and tumourigenic boundaries of glioblastoma plasticity

MI De Silva, BW Stringer, C Bardy - Trends in cancer, 2023 - cell.com
Glioblastoma (GBM) remains the most lethal primary brain cancer largely due to recurrence
of treatment-resistant disease. Current therapies are ultimately ineffective as GBM tumour …

Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer

RA Sample, MF Nogueira, RD Mitra, SV Puram - Oncogene, 2023 - nature.com
Epithelial-to-mesenchymal transition (EMT) is a process by which cells lose their epithelial
characteristics and gain mesenchymal phenotypes. In cancer, EMT is thought to drive tumor …

Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics

F Zhong, Y Lin, L Zhao, C Yang, Y Ye… - British Journal of Cancer, 2023 - nature.com
In recent years, the tumour microenvironment (TME) of solid tumours has attracted more and
more attention from researchers, especially those non-tumour components such as immune …

[PDF][PDF] Oncohistones: Exposing the nuances and vulnerabilities of epigenetic regulation

MM Mitchener, TW Muir - Molecular cell, 2022 - cell.com
Work over the last decade has uncovered a new layer of epigenetic dysregulation. It is now
appreciated that somatic missense mutations in histones, the packaging agents of genomic …